Iranian Red Crescent Medical Journal

Published by: Kowsar

The Prevalence of Toxoplasma gondii in Hemodialysis Patients

Masomeh Bayani 1 , Amrollah Mostafazadeh 2 , Farsheed Oliaee 3 and Narges Kalantari 4 , *
Authors Information
1 Department of Infectious Diseases and Tropical Research Center, Babol University of Medical Sciences, Babol, IR Iran
2 Department of Microbiology-Immunology, Babol University of Medical Sciences, Babol, IR Iran
3 Department of Internal Medicine, Babol University of Medical Sciences, Babol, IR Iran
4 Cellular and Molecular Biology Research Center, Babol University of Medical Sciences, Babol, IR Iran
Article information
  • Iranian Red Crescent Medical Journal: October 5, 2013, 15 (10); e5225
  • Published Online: October 5, 2013
  • Article Type: Letter
  • Received: April 17, 2012
  • Revised: July 14, 2012
  • Accepted: October 20, 2012
  • DOI: 10.5812/ircmj.5225

To Cite: Bayani M, Mostafazadeh A, Oliaee F, Kalantari N. The Prevalence of Toxoplasma gondii in Hemodialysis Patients, Iran Red Crescent Med J. 2013 ; 15(10):e5225. doi: 10.5812/ircmj.5225.

Copyright © 2013, Iranian Red Crescent Medical Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Acknowledgements
Footnotes
References
  • 1. Weiss LM, Dubey JP. Toxoplasmosis: A history of clinical observations. Int J Parasitol. 2009; 39(8): 895-901[DOI][PubMed]
  • 2. Dalimi A, Abdoli A. Latent Toxoplasmosis and Human. Iran J Parasitol. 2012; 7(1): 1-17
  • 3. Eleftheriadis T, Antoniadi G, Liakopoulos V, Kartsios C, Stefanidis I. Disturbances of acquired immunity in hemodialysis patients. Semin Dial. 2007; 20(5): 440-51[DOI][PubMed]
  • 4. Nissapatorn V, Leong TH, Lee R, Init I, Ibrahim J, Yen TS. Seroepidemiology of toxoplasmosis in renal patients. Southeast Asian J Trop Med Public Health. 2011; 42(2): 237-47[PubMed]
  • 5. Chacin-Bonilla L, Sanchez-Chavez Y, Monsalve F, Estevez J. Seroepidemiology of toxoplasmosis in amerindians from western Venezuela. Am J Trop Med Hyg. 2001; 65(2): 131-5[PubMed]
  • 6. Mostafavi SN, Ataei B, Nokhodian Z, Yaran M, Babak A. Seroepidemiology of Toxoplasma gondii infection in Isfahan province, central Iran: A population based study. J Res Med Sci. 2011; 16(4): 496-501[PubMed]
  • 7. Jones JL, Muccioli C, Belfort R, Jr., Holland GN, Roberts JM, Silveira C. Recently acquired Toxoplasma gondii infection, Brazil. Emerg Infect Dis. 2006; 12(4): 582-7[DOI][PubMed]
  • 8. Lappalainen M, Hedman K. Serodiagnosis of toxoplasmosis. The impact of measurement of IgG avidity. Ann Ist Super Sanita. 2004; 40(1): 81-8[PubMed]
  • 9. Filisetti D, Candolfi E. Immune response to Toxoplasma gondii. Ann Ist Super Sanita. 2004; 40(1): 71-80[PubMed]
  • 10. Yokoyama T, Nitta K, Futatsuyama K, Hayashi T, Honda K, Uchida K, et al. Identification of T helper cell subsets in continuous ambulatory peritoneal dialysis patients. Nephron. 2001; 89(2): 215-8[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments